Ionis Pharmaceuticals (IONS) Payables: 2009-2025
Historic Payables for Ionis Pharmaceuticals (IONS) over the last 16 years, with Sep 2025 value amounting to $14.3 million.
- Ionis Pharmaceuticals' Payables rose 58.26% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.5 million, marking a year-over-year increase of 69.93%. This contributed to the annual value of $43.0 million for FY2024, which is 65.07% up from last year.
- According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Payables is $14.3 million, which was down 37.17% from $22.8 million recorded in Q2 2025.
- In the past 5 years, Ionis Pharmaceuticals' Payables ranged from a high of $43.0 million in Q4 2024 and a low of $5.6 million during Q3 2023.
- Its 3-year average for Payables is $17.7 million, with a median of $14.3 million in 2025.
- Per our database at Business Quant, Ionis Pharmaceuticals' Payables crashed by 72.67% in 2023 and then skyrocketed by 146.67% in 2025.
- Over the past 5 years, Ionis Pharmaceuticals' Payables (Quarterly) stood at $11.9 million in 2021, then soared by 50.55% to $17.9 million in 2022, then skyrocketed by 45.23% to $26.0 million in 2023, then spiked by 65.07% to $43.0 million in 2024, then surged by 58.26% to $14.3 million in 2025.
- Its last three reported values are $14.3 million in Q3 2025, $22.8 million for Q2 2025, and $17.5 million during Q1 2025.